Insider track record Other Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by David Redfern. Insider active across 1 company, notably GSK plc. Aggregated, 117 disclosures have been logged. Activity tracked since 9 August 2023. The latest transaction was filed on 11 August 2026 (Purchase). Regulator: RNS (LSE). The full history is free.
Companies and markets linked to David Redfern Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations 117 total
● President, Corporate Development · Executives · 11 Aug 2026 · GSK plc 14 shares @ £19.3493 ISIN ISIN GB00BN7SWP63RNS:9721245-3 ● President, Corporate Development · Executives · 11 Aug 2026 · GSK plc 14 shares @ £19.3493 0.0000% mcap 0.0% of flow ISIN ISIN GB00BN7SWP63FCA-NSM:802aebe3-75c1-4ba5-8333-3c8ccb6de1b0-3 ● President Corporate Development · Executives · 13 Jul 2026 · GSK plc 6 shares @ £19.755 0.0000% mcap 0.0% of flow ISIN ISIN GB00BN7SWP63RNS:9668630-13 ● President Corporate Development · Executives · 9 Jul 2026 · GSK plc 5,803.725 shares @ £19.6297 0.015% mcap 0.6% of flow ISIN ISIN GB00BN7SWP63RNS:9668630-6 ● President, Corporate Development · Executives · 10 Jul 2026 · GSK plc 784 shares @ £19.595 0.0020% mcap 0.1% of flow ISIN ISIN GB00BN7SWP63RNS:9668630-19 ● President Corporate Development · Executives · 13 Jul 2026 · GSK plc 18 shares @ £19.755 0.0000% mcap 0.0% of flow ISIN ISIN GB00BN7SWP63RNS:9668630-24 ● President Corporate Development · Executives · 9 Jul 2026 · GSK plc 0
ISIN ISIN GB00BN7SWP63RNS:0920c70b-f075-4c99-aba0-46720a29730a-6 ● President Corporate Development · Executives · 9 Jul 2026 · GSK plc 70 shares @ £19.629 0.0002% mcap 0.0% of flow ISIN ISIN GB00BN7SWP63RNS:9666294-12 ● President, Corporate Development · Executives · 9 Jul 2026 · GSK plc 12 shares @ £19.6292 0.0000% mcap 0.0% of flow ISIN ISIN GB00BN7SWP63RNS:9666294-3 ● President, Corporate Development · Executives · 9 Jul 2026 · GSK plc 12 shares @ £19.6292 0.0000% mcap 0.0% of flow ISIN ISIN GB00BN7SWP63RNS:06e0a094-373b-4460-b97c-91525b0dd5d9-3 ● President Corporate Development · Executives · 9 Jul 2026 · GSK plc 70 shares @ £19.629 0.0002% mcap 0.0% of flow ISIN ISIN GB00BN7SWP63RNS:06e0a094-373b-4460-b97c-91525b0dd5d9-12 ● President, Corporate Development · Executives · 9 Jun 2026 · GSK plc 14 shares @ £18.8393 0.0000% mcap 0.0% of flow ISIN ISIN GB00BN7SWP63RNS:9614374-3 ● President, Corporate Development · Executives · 9 Jun 2026 · GSK plc 14 shares @ £18.8393 0.0000% mcap 0.0% of flow ISIN ISIN GB00BN7SWP63RNS:03338973-0058-4811-9fe5-7b22157346a2-3 ● President, Corporate Development · Executives · 12 May 2026 · GSK plc 14 shares @ £18.778 0.0000% mcap 100.0% of flow ISIN ISIN GB00BN7SWP63RNS:9569357-3 ● President, Corporate Development · Executives · 12 May 2026 · GSK plc 14 shares @ £18.6557 0.0000% mcap 0.0% of flow ISIN ISIN GB00BN7SWP63RNS:eaad27f1-a91f-4bc4-815a-149202956de0-3 ● President, Corporate Development · Executives · 14 Apr 2026 · GSK plc 745 shares @ £21.67 0.0000% mcap 0.1% of flow ISIN ISIN GB00BN7SWP63RNS:ca89baf1-aabf-4020-b0fe-d5c65c1b3a57-5 ● President, Corporate Development · Executives · 13 Apr 2026 · GSK plc 10 shares @ £21.709 0.0000% mcap 0.0% of flow ISIN ISIN GB00BN7SWP63RNS:bae2311e-28b0-4835-a894-0209eedccba9-3 ● President Corporate Development · Executives · 10 Apr 2026 · GSK plc 6 shares @ £21.6967 0.0000% mcap 0.0% of flow ISIN ISIN GB00BN7SWP63RNS:66208821-3d67-43ba-837e-411f45d449f1-2 ● President Corporate Development · Executives · 10 Apr 2026 · GSK plc 17 shares @ £21.6965 0.0000% mcap 0.0% of flow ISIN ISIN GB00BN7SWP63RNS:66208821-3d67-43ba-837e-411f45d449f1-0 ● President Corporate Development · Executives · 9 Apr 2026 · GSK plc 0
ISIN ISIN GB00BN7SWP63RNS:66208821-3d67-43ba-837e-411f45d449f1-10 ● President Corporate Development · Executives · 9 Apr 2026 · GSK plc 67 shares @ £21.3387 0.0000% mcap 0.0% of flow ISIN ISIN GB00BN7SWP63RNS:5b5d692c-e307-4a46-a436-f5464b4ee34b-4 ● President, Corporate Development · Executives · 10 Mar 2026 · GSK plc 12 shares @ £20.7167 0.0% of flow ISIN ISIN GB00BN7SWP63RNS:08be650c-10c4-4fa5-9cae-5b89efa04716-3 ● President, Corporate Development · Executives · 13 Feb 2026 · GSK plc 80,511 shares @ £21.6002 9.2% of flow ISIN ISIN GB00BN7SWP63RNS:9e068048-67e6-4a53-8636-ebe7180e6da4-17 ● President, Corporate Development · Executives · 13 Feb 2026 · GSK plc 171,300 shares 0
ISIN ISIN GB00BN7SWP63RNS:9e068048-67e6-4a53-8636-ebe7180e6da4-16 ● President, Corporate Development · Executives · 12 Feb 2026 · GSK plc 143,579 shares @ £21.50 16.4% of flow ISIN ISIN GB00BN7SWP63RNS:586c5c74-54b9-425a-a37c-ba21836ecce7-9 25 of 117 declarations
Load more (92 remaining) About David Redfern David Redfern is President, Corporate Development at GSK plc (XLON). He has 105 filings in total, and across the sampled recent filings from 2023-08-10 to 2026-06-12, purchases amount to EUR 40049 and sales to EUR 9182238, with Purchase as the modal transaction nature.